EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC 4.0

Association between protein dose in the early and late acute phases of critical illness and time‐to‐discharge‐alive: A secondary analysis of a randomized clinical trial

Lauren E Tweel iD, Rebecca Brody iD, Hamed Samavat iD, Andrew G Day, Xuran Jiang, Laura Byham-Gray iD, Jayshil Patel iD, Charlene Compher iD, Daren K Heyland iD

Journal of Parenteral and Enteral Nutrition · 2026-02 · 50 (2) · 183-191

DOI: 10.1002/jpen.70033 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Parenteral and Enteral Nutrition, online erschienen am 14.11.2025. Verfasst von Lauren E Tweel und 8 weiteren Autor:innen. Beteiligte Einrichtung: Foothills Medical Centre, Alberta Health Services, Calgary, Alberta, Canada. Hauptthemen laut MEDLINE: Critical Illness, Patient Discharge, Dietary Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Research has sought to identify optimal protein doses during acute phases of critical illness to optimize outcomes.

Methods

A secondary analysis of the EFFORT Protein trial, which compared high vs usual protein ( N = 1301). Only participants with 8 evaluable days of protein intake were included in our analysis. Mean protein intake was categorized as low (1.3 g/kg/day). Acute illness phases were define as early (days 1–4) and late (days 5–8). Participants were grouped by protein dose received in each phase. Based on prior evidence, early phase medium protein/late phase high protein served as the referent. The primary outcome was time‐to‐discharge‐alive; secondary outcomes included 60‐day mortality and discharge home.

Results

We identified 819 participants (median [IQR] age 59.0 [46.0, 69.0] years; 60% male). Time‐to‐discharge‐alive did not differ significantly across groups ( P = 0.19). The early low/late high‐protein and early high/late high‐protein groups had hazard ratios of 0.63 (95% CI, 0.35–1.11) and 0.70 (95% CI, 0.46–1.06), respectively. Mortality and discharge‐home rates did not differ significantly across protein dose/acute phase groups ( P = 0.85 and 0.65, respectively).

Conclusion

We hypothesized that early medium and late high protein would improve outcomes; however, no significant differences between were observed across protein dose/acute phase groups. These findings are hypothesis‐generating and highlight the need for future research to identify biomarkers or scoring tools that better define phase transitions in critical illness, enabling more precise nutrition strategies. Trial Registration (Primary) NCT03160547

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Critical IllnessPatient DischargeDietary ProteinsHumansMaleFemaleMiddle AgedAgedTime FactorsAcute DiseaseLength of Stay

Stichwörter der Autor:innen

acute phasecritically illenteral nutritionmortalitynutrition supportprotein

Substanzen

Dietary Proteins

Autor:innen und Institutionen

  • Foothills Medical Centre, Alberta Health Services, Calgary, Alberta, Canada.
  • Department of Clinical and Preventive Nutrition Sciences, School of Health Professions, Rutgers University, Rutgers, New Jersey, USA.
  • Kingston Health Science Centre Research Institute, Kingston, Ontario, Canada.
  • Queen's University, Kingston, Ontario, Canada.
  • Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
  • School of Nursing, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

ORCID-Profile: Lauren E Tweel, Rebecca Brody, Hamed Samavat, Laura Byham-Gray, Jayshil Patel, Charlene Compher, Daren K Heyland

Zitieren

APA

Tweel, L. E., Brody, R., Samavat, H., Day, A. G., Jiang, X., Byham-Gray, L., Patel, J., Compher, C., & Heyland, D. K. (2026). Association between protein dose in the early and late acute phases of critical illness and time‐to‐discharge‐alive: A secondary analysis of a randomized clinical trial. Journal of Parenteral and Enteral Nutrition, 50(2), 183-191. https://doi.org/10.1002/jpen.70033

Vancouver

Tweel LE, Brody R, Samavat H, Day AG, Jiang X, Byham-Gray L, et al. Association between protein dose in the early and late acute phases of critical illness and time‐to‐discharge‐alive: A secondary analysis of a randomized clinical trial. Journal of Parenteral and Enteral Nutrition. 2026;50(2):183-191. doi:10.1002/jpen.70033

BibTeX
@article{Tweel2026,
  author = {Tweel, Lauren E and Brody, Rebecca and Samavat, Hamed and Day, Andrew G and Jiang, Xuran and Byham-Gray, Laura and Patel, Jayshil and Compher, Charlene and Heyland, Daren K},
  title = {Association between protein dose in the early and late acute phases of critical illness and time‐to‐discharge‐alive: A secondary analysis of a randomized clinical trial},
  journal = {Journal of Parenteral and Enteral Nutrition},
  year = {2026},
  volume = {50},
  number = {2},
  pages = {183--191},
  doi = {10.1002/jpen.70033}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche